111

LCB

No trades
See on Supercharts
Market capitalization
‪2.38 T‬KRW
−2800KRW
‪−73.70 B‬KRW
‪34.15 B‬KRW
‪22.14 M‬
Beta (1Y)
1.78

About LCB

CEO
Yong-Zu Kim
Headquarters
Daejeon
Employees (FY)
147
Founded
2006
ISIN
KR7141080002
FIGI
BBG004D9DST0
LigaChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. It offers medical equipment and therapeutic products such as antibiotics, anti-coagulants, oncology, antibody-drug conjugate, and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 141080 is 65500 KRW — it has decreased by 1.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange LCB stocks are traded under the ticker 141080.
141080 stock is 5.54% volatile and has beta coefficient of 1.78. Check out the list of the most volatile stocks — is LCB there?
Yes, you can track LCB financials in yearly and quarterly reports right on TradingView.
141080 stock has risen by 5.48% compared to the previous week, the month change is a 10.76% fall, over the last year LCB has showed a 71.24% increase.
141080 net income for the last quarter is ‪−16.15 B‬ KRW, while the quarter before that showed ‪−19.77 B‬ KRW of net income which accounts for 18.28% change. Track more LCB financial stats to get the full picture.
Today LCB has the market capitalization of ‪2.38 T‬, it has increased by 3.61% over the last week.
No, 141080 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 141080 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LCB stock right from TradingView charts — choose your broker and connect to your account.
141080 reached its all-time high on Mar 11, 2024 with the price of 84000 KRW, and its all-time low was 5600 KRW and was reached on Jun 25, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 147.00 employees. See our rating of the largest employees — is LCB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LCB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LCB stock shows the buy signal. See more of LCB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LCB future price: according to them, 141080 price has a max estimate of 100000.00 KRW and a min estimate of 92000.00 KRW. Read a more detailed LCB forecast: see what analysts think of LCB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LCB EBITDA is ‪−76.93 B‬ KRW, and current EBITDA margin is −225.28%. See more stats in LCB financial statements.